Literature DB >> 19158282

Detection of (1-->3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation.

María Soledad Cuétara1, Almudena Alhambra, María Dolores Moragues, Ernesto González-Elorza, José Pontón, Amalia del Palacio.   

Abstract

This single-center observational prospective study evaluated the performance of (1-->3)-beta-D-glucan as an adjunct diagnostic tool in 12 patients with proven invasive fungal disease with different risk factors. The infections were due to either uncommon fungal pathogens such as dematiaceous molds (Scedosporium apiospermum, Alternaria infectoria, and Cladosporium macrocarpum) and hyaline septate molds (Fusarium solani and Blastoschizomyces capitatus) or Aspergillus spp. with unusual clinical presentations.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19158282      PMCID： PMC2650859          DOI： 10.1128/CVI.00009-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  13 in total

Review 1.  Infections due to emerging and uncommon medically important fungal pathogens.

Authors:  T J Walsh; A Groll; J Hiemenz; R Fleming; E Roilides; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

2.  Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

Authors:  Georgios Chamilos; Mario Luna; Russell E Lewis; Gerald P Bodey; Roy Chemaly; Jeffrey J Tarrand; Amar Safdar; Issam I Raad; Dimitrios P Kontoyiannis
Journal:  Haematologica       Date:  2006-06-01       Impact factor: 9.941

3.  Invasive aspergillosis due to subungual onychomycosis during treatment for non-Hodgkin lymphoma.

Authors:  M S Cuétara; A Alhambra; J M Moreno; C Postigo; M D Moragues; J Pontón; A del Palacio
Journal:  Br J Dermatol       Date:  2006-06       Impact factor: 9.302

4.  Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Authors:  Luis Ostrosky-Zeichner; Barbara D Alexander; Daniel H Kett; Jose Vazquez; Peter G Pappas; Fumihiro Saeki; Paul A Ketchum; John Wingard; Robert Schiff; Hiroshi Tamura; Malcolm A Finkelman; John H Rex
Journal:  Clin Infect Dis       Date:  2005-07-21       Impact factor: 9.079

5.  Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations.

Authors:  Per Sandven; Hanne Qvist; Eva Skovlund; Karl E Giercksky
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

6.  Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.

Authors:  Carmen Pazos; José Pontón; Amalia Del Palacio
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 7.  Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis.

Authors:  Anthony J Michaels; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

8.  Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Zekaver Odabasi; Gloria Mattiuzzi; Elihu Estey; Hagop Kantarjian; Fumihiro Saeki; Richard J Ridge; Paul A Ketchum; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Journal:  Clin Infect Dis       Date:  2004-06-28       Impact factor: 9.079

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 10.  Primary central nervous system phaeohyphomycosis: a review of 101 cases.

Authors:  Sanjay G Revankar; Deanna A Sutton; Michael G Rinaldi
Journal:  Clin Infect Dis       Date:  2003-12-19       Impact factor: 9.079
View more
  16 in total

1.  Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis.

Authors:  Jennifer L Lyons; Karen L Roos; Kieren A Marr; Henry Neumann; Julie B Trivedi; Dorlan J Kimbrough; Lisa Steiner; Kiran T Thakur; Daniel M Harrison; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

Review 2.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.

Authors:  Pamela Thomson; Josep Guarro; Emilio Mayayo; Javier Capilla
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  Successful Posaconazole Therapy of Disseminated Alternariosis due to Alternaria infectoria in a Heart Transplant Recipient.

Authors:  Pavlina Lyskova; Milos Kubanek; Vit Hubka; Eva Sticova; Ludek Voska; Dana Kautznerova; Miroslav Kolarik; Petr Hamal; Martina Vasakova
Journal:  Mycopathologia       Date:  2016-11-19       Impact factor: 2.574

5.  Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.

Authors:  Paul E Sax; Lauren Komarow; Malcolm A Finkelman; Philip M Grant; Janet Andersen; Eileen Scully; William G Powderly; Andrew R Zolopa
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

Review 6.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 7.  Emerging fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

Review 8.  Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.

Authors:  Matthew W McCarthy; Ruta Petraitiene; Thomas J Walsh
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

9.  Serological response and diagnostic value of recombinant candida cell wall protein enolase, phosphoglycerate kinase, and β-glucosidase.

Authors:  Zheng-Xin He; Jing Chen; Wei Li; Yan Cheng; Hai-Pu Zhang; Li-Na Zhang; Tian-Wen Hou
Journal:  Front Microbiol       Date:  2015-09-10       Impact factor: 5.640

Review 10.  Phaeohyphomycosis in Transplant Patients.

Authors:  Sanjay G Revankar
Journal:  J Fungi (Basel)       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.